Yahoo Web Search

Search results

    • FDA Approves Merck's Vaccine For Adult Invasive Pneumococcal Disease

      Morningstar· 4 hours ago

      By Emon Reiser The Food and Drug Administration approved Merck's Capvaxive, a vaccine to prevent the invasive bacterial infection pneumococcal disease in adults age 50 or older. Merck said that across four Phase 3 studies, Capvaxive "demonstrated

    • Vaccine exemption rates are on the rise in Texas schools

      Community Impact· 9 hours ago

      Vaccination rates in school-age children were high for the 2022-23 school year, but increasing conscientious exemption rates and lingering pandemic disruptions prevent them from being higher ...